Regulatory Affairs for Phase I-II

Regulatory strategy is not a checkpoint at submission, it is a core driver of successful early development. Early-stage biotechs and academic sponsors operate in a complex and rapidly evolving regulatory environment where clarity, timing, and scientific alignment are critical.

INVENTIO science embeds senior regulatory experts directly into your programs to provide pragmatic guidance across nonclinical and clinical strategy, regulatory writing, and health authority interactions. Our FSP model supports confident decision-making and ensures development pathways remain aligned with global regulatory expectations from preclinical stages through approval.

Our Regulatory Services Include:

• Early-phase regulatory strategy (IND/CTA pathway planning)
• Regulatory submission planning and coordination
• IND/CTA preparation, submission, and lifecycle maintenance
• Health authority meeting preparation and support
• Regulatory intelligence and competitive landscape assessment
• CMC regulatory coordination for early clinical development
• Clinical trial authorization management and amendments
• Medical writing support for regulatory documents
• Safety and regulatory alignment across development program